India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Global Market
Related Markets
India veterinary active pharmaceutical ingredients manufacturing market highlights
- The India veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 547.7 million in 2024 and is expected to reach USD 1,133.3 million by 2033.
- The India market is expected to grow at a CAGR of 8.4% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
| Market revenue in 2024 | USD 547.7 million |
| Market revenue in 2033 | USD 1,133.3 million |
| Growth rate | 8.4% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, India accounted for 5.9% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,133.3 million by 2033.
The veterinary API manufacturing market in India is expected to grow unprecedentedly over the forecast period. Growth in the country can be attributed to the increased government efforts to drive veterinary healthcare facilities and numerous funding schemes by state & national agencies.
As per the Government of India’s Open Government Data Platform, India had roughly 12,000 veterinary hospitals and polyclinics in 2021. The states of Rajasthan, Uttar Pradesh, and Punjab collectively accounted for over 50% of the country’s veterinary hospitals and polyclinics.
The government is providing funds to establish & strengthen existing veterinary hospitals and dispensaries, creating growth opportunities in India. Furthermore, key players are adopting numerous strategies, such as acquisitions, partnerships, product launches, and business developments, which is expected to drive market growth.
No credit card required*
Publish Date: Nov 25, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | www.menadiona.com/ |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | sequent.in |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | ofichem.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.chemprogroup.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | siflonpharma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | vetpharma.com |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | www.suanfarma.com |
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.excelind.co.in |
India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook will help companies and investors design strategic landscapes.
In House was the largest segment with a revenue share of 60.78% in 2024.
Horizon Databook has segmented the India veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary API manufacturing market in India is expected to grow unprecedentedly over the forecast period. Growth in the country can be attributed to the increased government efforts to drive veterinary healthcare facilities and numerous funding schemes by state & national agencies.
As per the Government of India’s Open Government Data Platform, India had roughly 12,000 veterinary hospitals and polyclinics in 2021. The states of Rajasthan, Uttar Pradesh, and Punjab collectively accounted for over 50% of the country’s veterinary hospitals and polyclinics.
The government is providing funds to establish & strengthen existing veterinary hospitals and dispensaries, creating growth opportunities in India. Furthermore, key players are adopting numerous strategies, such as acquisitions, partnerships, product launches, and business developments, which is expected to drive market growth.
- India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Service Type Outlook (Revenue, USD Million , 2021-2033)
- In House
- Contract Outsourcing
- India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Synthesis Type Outlook (Revenue, USD Million , 2021-2033)
- Chemical Based API
- Biological API
- HPAPI
- India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Therapeutic Category Outlook (Revenue, USD Million , 2021-2033)
- Antiparasitics
- Anti-infectives
- NSAIDs
- Others
- India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
Reasons to subscribe to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Our clientele includes a mix of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2021-2033 (US$M)
India Service Type - Veterinary Active Pharmaceutical Ingredients Manufacturing Market Statistics, 2024 - 2033 (US$M)
